Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Sofia Michael J., Executive. Officer active across 1 company, notably Arbutus Biopharma Corp. Cumulatively, 3 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €898k. History available since 1 December 2021. The latest transaction was disclosed on 1 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Michael J. Sofia is the Chief Scientific Officer at Arbutus Biopharma Corp. In this role, he is responsible for leading the company's research and development efforts, which focus on antiviral treatments. Sofia plays a key role in scientific innovation and the development of new therapies.